Reovirus may be a novel approach to prostate cancer treatment
March 10th, 2010 Posted in prostate cancerAccording to study results, Canadian researchers have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus.
The respiratory, enteric, orphan virus (commonly known as reovirus) is a non-attenuated, environmental virus that has shown oncolytic potential against many types of cancer, specifically lymphoid, ovarian, breast, pancreatic and high grade glioma cancer, according to the study. This is the first time the virus has been studied against prostate cancer.
Research study was published in Cancer Research, a journal of the American Association for Cancer Research.